Medication info

Twinuro Tablet 80/5mg

Prescription medicationTabletOralExpired
Ingredient · strength
Telmisartan Powder 23.9%›334.72mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Medics Pharmaceutical Co., Ltd.
Appearance
Biconvex oval bicolor tablets of white and light gray
Packaging
30 tablets per box [(10 tablets / PTP X 3)]
Approval status
Expired

MFDS item code 201901406 · Approved 2019.03.08

This product's status changed to Expired on 2024.03.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medication is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan); however, if blood pressure is not controlled with the individual components as described below, switching directly to this medication may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medication 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is required for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section “3. Patients requiring caution in administration.”) In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a lower dose and increase the dose gradually.
Child dose
Use of this medication is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
Medics Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively control the blood pressure of patients with essential hypertension who do not have adequate control with monotherapy with amlodipine or telmisartan.

How to take

Adult dose

The recommended dose of this medication is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan); however, if blood pressure is not controlled with the individual components as described below, switching directly to this medication may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medication 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is required for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section “3. Patients requiring caution in administration.”) In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a lower dose and increase the dose gradually.

Child dose

Use of this medication is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.

Precautions

This drug can pose a serious risk to the fetus, especially during the second and third trimesters, so if pregnancy is confirmed, the drug must be discontinued immediately. Patients with allergies to the components of this drug or similar drugs, women who are pregnant or may become pregnant, nursing mothers, and patients with severe liver or heart problems should not take this medication. Patients with impaired liver function, gastrointestinal diseases, kidney problems, and the elderly should use this medication with caution and adjust the dosage according to a doctor's instructions if necessary. Side effects such as dizziness or edema may commonly occur with this medication, and more serious side effects may occur in rare cases; therefore, if symptoms are severe, consult a healthcare professional immediately. There is a risk of blood pressure dropping too low or potassium levels increasing, so patients with impaired kidney function should regularly check their condition through blood tests. This medication may interact with other drugs, so if you are taking other medications, be sure to inform your doctor or pharmacist, and it is advisable to avoid taking it with grapefruit juice. Women who are pregnant or planning to become pregnant, as well as nursing mothers, should not take this medication; if pregnancy is confirmed, discontinue use immediately and discuss alternative treatment options. This medication is not recommended for children as its safety and efficacy have not been sufficiently established in pediatric patients. The elderly may be more sensitive to this drug, starting with a lower dose and gradually increasing it is safer. In case of overdose, symptoms such as hypotension or heart problems may occur, and appropriate treatment should be sought immediately at the hospital. This drug should be kept out of reach of children and should not be transferred to another container.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 96 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory abnormalities
  • sensory loss
  • taste disturbance
  • tremors
  • extrapyramidal disorder
  • muscle hypertonicity
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver disorder
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • sweating
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • vascular edema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal impairment
  • urination disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • weakness
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • reduced hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light, so it should be stored in a container that protects it from light. Also, it is recommended to store the drug at room temperature between 1 and 30 degrees Celsius. By doing so, the effectiveness of the drug can be maintained and degradation prevented.

Appearance and packaging

Appearance

Biconvex oval bicolor tablets of white and light gray

Package unit

30 tablets per box [(10 tablets / PTP X 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.